RNA-Engineered Cell Therapy with Cartesian's Dr. Murat Kalayoglu
Business Of Biotech - Podcast autorstwa Matt Pillar - Poniedziałki
Kategorie:
We love to hear from our listeners. Send us a message. Cartesian President & CEO Murat Kalayoglu, M.D., Ph.D. has led three of his company's six autoimmune, oncology, and respiratory candidates through Phase I/II clinical trials and two more of them are on the cusp of entering Phase I this year. With so many programs in and entering the clinic, he's a great choice for a conversation on GMP expectations for phase I first-in-human trials. Glean insight from Cartesian's experienc...
